NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Clinical data updates for the Company’s two lead product candidates in Phase 1/2 clinical trials…
Clinical data updates for the Company’s two lead product candidates in Phase 1/2 clinical trials…
NEW HAVEN, Conn., March 09, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
CONSHOHOCKEN, Pa., March 09, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage…
Montrouge, France, March 9, 2022 DBV Technologies Announces Filing of 2021 Annual Report on Form…
BRIDGEWATER, N.J., March 09, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or…
SEATTLE, March 09, 2022 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused…
Zurich, Switzerland–(Newsfile Corp. – March 9, 2022) – Today, LUDO announced that Miko Matsumura has signed…
Toronto, Ontario–(Newsfile Corp. – March 9, 2022) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
The INNOVATION FACTORI provides digital innovation for customers, driving AI at enterprise scale HOUSTON–(BUSINESS WIRE)–Schlumberger…
The INNOVATION FACTORI provides digital innovation for customers, driving AI at enterprise scale HOUSTON–(BUSINESS WIRE)–Regulatory…
Continued Managed Service Provider Adoption and Hybrid Cloud Momentum Fuel Subscription Revenue Growth Generated a…
CHICAGO–(BUSINESS WIRE)–Interior Define, the digitally native and vertically integrated customizable furniture brand, announces today the…
West Virginia school district renews PowerSchool Unified Talent SmartFind Express to future-proof substitute management operations…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 35 classes of mortgage pass-through certificates from OBX…
NEW YORK–(BUSINESS WIRE)–CI&T (NYSE: CINT, “Company”), a global digital specialist, today announces its unaudited results…
Highlights: Rambus RT-640 Embedded Hardware Security Module (HSM) provides automotive chip and device makers state-of-the-art…
LEXINGTON, Mass., March 09, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…
– Topline results for ongoing Phase 2 clinical trial in ulcerative colitis and Phase 2a…
SAN FRANCISCO, March 09, 2022 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company…
NEW YORK and SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq:…